KARL STORZ Endoscopy-America, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
KARL STORZ Endoscopy-America, Inc. - overview
Established
1945
Location
Tuttlingen, -, Germany
Primary Industry
Medical Devices & Equipment
About
KARL STORZ is a renowned company specializing in the development and manufacturing of innovative endoscopic equipment and solutions for various medical fields, enhancing surgical precision and patient care. Founded in 1945 in Tuttlingen, Germany, KARL STORZ focuses on medical endoscopy solutions. The company has evolved its product line to cater to various specialties, including surgery and gynecology. It operates globally, with its headquarters in Tuttlingen, and has made strategic shifts to enhance its product offerings in response to market demands.
KARL STORZ specializes in innovative endoscopic equipment and solutions tailored for various medical specialties, including general and visceral surgery, urology, otorhinolaryngology, airway management, and gynecology. The company's core offerings involve advanced laparoscopic instruments, precision telescopes, and minimally invasive surgical devices designed for challenging medical procedures. These products enable healthcare professionals to improve patient outcomes through enhanced visualization and streamlined workflows in operating rooms. With a client base that includes hospitals, surgical centers, and healthcare providers worldwide, KARL STORZ serves markets in North America, Europe, Asia, and other regions, delivering solutions that address chronic medical conditions and enhance surgical capabilities.
KARL STORZ generated revenue of USD 2,359. 31 mn in the most recent fiscal year 2023, with an EBITDA of USD 93. 39 mn. The company generates revenue through direct sales of its specialized medical devices and solutions, often engaging in B2B transactions with healthcare institutions.
The business model includes structured partnerships with hospitals and surgical centers, facilitating bulk purchases of both instruments and service agreements to ensure ongoing support and maintenance. The transactions typically involve service contracts that cover equipment servicing plans and customer support, allowing clients to maintain optimal functionality of their medical devices. With flagship products such as the pioneering video laryngoscope and a diverse range of endoscopic imaging solutions, KARL STORZ positions itself as a leader in the medical technology market.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Biomaterials
Website
www.karlstorz.com
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.